This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

10 Sleazy Celebrity Endorsements

Jimmy Johnson
As a football coach -- especially as the brash, good ol' boy who led the Miami Hurricanes and Dallas Cowboys -- Jimmy Johnson was never shy about voicing his opinions. As a Fox (NWS - Get Report) Network football analyst, he continues to be an opinionated, polarizing figure.

Apparently, what allows him to be so colorful is a lack of shame. How else to explain his endorsement deal with ExtenZe, an herbal supplement billed as "natural male enhancement."

The ads use various euphemisms to get around actually saying "larger penis." That might have something to do with a 2006 fine of $300,000 levied by the Orange County, Calif., District Attorney's Office for false advertising, notable an inability to support claims it could grow the appendage in question by nearly a third its size. Even an ingredient known to botanists as "horny goat weed" may not be able to live up to that promise.

Despite the occasional class-action suit and the embarrassment most of us would feel to be telling America we are a proud user of such a supplement, Johnson seems at ease with his role.

He has described himself as an ""an unabashed user" and, in one commercial boasts: "Most men want to perform the best they can in just about everything ... Go long with ExtenZe. I do."

Some things just cannot be unseen or unheard.

7 of 12

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DFS $56.57 0.00%
HTZ $20.83 0.00%
KO $40.08 0.00%
MA $87.25 0.00%
NVO $53.84 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs